Streetbeat News

Stock Prices

DAL

LUV

UAL

Airline stocks are trading higher following United's report of better-than-expected Q4 results, indicating a positive market reaction to the airline industry's financial performance.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 6:36 pm

TEVA

Teva Pharmaceutical Industries' stock (TEVA) has seen an increase in its trading price following an upgrade from 'Hold' to 'Buy' by Jefferies, which also raised its price target for the stock from $10 to $14.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 6:24 pm

DWAC

SPY

Former President Donald Trump visited a polling place on the day of the New Hampshire primary. The article suggests potential implications for Digital World Acquisition Corp. (DWAC) and the broader market, as represented by the SPDR S&P 500 ETF Trust (SPY), due to Trump's influence on political and market sentiment.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 6:23 pm

GE

BofA Securities analyst Andrew Obin is optimistic about General Electric Company's (NYSE:GE) future, citing potential upside from the upcoming Vernova spin-off and growth in the Aerospace sector. GE's Q4 FY23 earnings surpassed expectations with adjusted revenue of $18.5 billion and adjusted EPS of $1.03. The company forecasts Q1 adjusted EPS of $0.60 to $0.65 and expects FY24 revenue of $34 billion-$35 billion for GE Vernova and low double-digit growth for GE Aerospace. Obin maintains a Buy rating on GE with a $135 price target.

Portfolio Pulse from Lekha Gupta

January 23, 2024 | 6:22 pm

JNJ

Johnson & Johnson (NYSE:JNJ) has reached a tentative settlement of approximately $700 million with 42 U.S. states and Washington, D.C., over allegations of misleading information about the safety of its talc products. This settlement does not include over 52,000 personal-injury lawsuits still pending. The company has faced setbacks in bankruptcy proceedings aimed at mass settlements, with a rejected $8.9 billion payout plan. JNJ shares dropped 1.43% to $160.15 following the news.

Portfolio Pulse from Vandana Singh

January 23, 2024 | 6:18 pm

WMT

Options trading activity for Walmart (NYSE:WMT) indicates a bullish sentiment among investors, with 56% of the trades being bullish and 43% bearish. The trading volume and open interest suggest that the market expects Walmart's stock to trade between $135.0 and $170.0. The largest options trades include bullish calls with expiration dates in 2024 and bearish puts expiring in 2024. Walmart is a leading retailer in the US, operating over 4,700 stores and generating over $420 billion in domestic sales. The stock price is slightly down with a current price of $162.22, and the RSI indicators suggest it may be approaching overbought territory. Walmart's next earnings report is expected in 28 days.

Portfolio Pulse from Benzinga Insights

January 23, 2024 | 6:16 pm

PCAR

PACCAR Inc. shares have risen following the announcement of their Q4 results, which exceeded market expectations.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 6:16 pm

NXPI

NXP Semiconductors' stock (NXPI) is trading higher following an initiation of coverage by Cantor Fitzgerald with an Overweight rating and a price target of $260.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 6:14 pm

LMT

Lockheed Martin's stock is trading lower after the company released its fourth-quarter earnings and provided its outlook for 2024, which may have disappointed investors.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 6:13 pm

ENSC

Ensysce Biosciences Inc (NASDAQ:ENSC) received an FDA Breakthrough Therapy Designation for its opioid PF614-MPAR, designed to provide pain relief while preventing overdose. The designation, granted to fewer than 300 drugs, will expedite the drug's development and review. ENSC's stock rose 42.20% to $1.62 following the news.

Portfolio Pulse from Vandana Singh

January 23, 2024 | 6:13 pm